Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
Clinical trial NCT03941483 · COMPLETED
Trial details
- NCT number
- NCT03941483
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-01
- Primary completion
- 2021-07-26
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.